242 studies found for:    "Gallbladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Los Angeles Prospective GI Biliary and EUS Series
Conditions: Biliary Disease;   Pancreatitis;   Gastrointestinal Neoplasms
Intervention: Other: clinical course
22 Recruiting Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
Conditions: Biliary Disease;   Pancreas Disease
Intervention: Procedure: Laparoscopy assisted ERCP
23 Completed Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique
Conditions: Biliary Diseases;   Pancreas Diseases
Interventions: Procedure: Team 1;   Procedure: Team 2
24 Recruiting EUS-Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy
Conditions: Disorders of Gallbladder;   Disorders of Biliary Tract
Interventions: Procedure: EUS-Rendezvous or direct intervention;   Procedure: Advanced ERCP Biliary Access Techniques
25 Completed Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Condition: Disorders of Gallbladder, Biliary Tract and Pancreas
Intervention: Drug: propofol
26 Completed
Has Results
Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.
Condition: Disorders of Gallbladder, Biliary Tract and Pancrease
Interventions: Drug: Propofol;   Drug: Midazolam;   Drug: Meperidine
27 Not yet recruiting Transient ECG Changes in Patients With Acute Biliary Disease
Conditions: Acute Cholecystitis;   Biliary Colic;   Acute Cholangitis
Intervention:
28 Completed
Has Results
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Gastrointestinal Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer
Interventions: Drug: erlotinib hydrochloride;   Biological: bevacizumab
29 Unknown  Study of the Use of Humidified Warmed Gas and the Effect on Post-Operative Pain in Laparoscopic Cholecystectomies
Condition: Gallstone
Interventions: Other: Warm humidified C02;   Other: Cool dry C02
30 Terminated Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy
Conditions: Choledocholithiasis;   Cholelithiasis
Intervention: Procedure: Transcystic Stenting (Facilitated ERCP)
31 Terminated Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy
Condition: Cholelithiasis
Intervention: Procedure: Laparoscopic-assisted transvaginal cholecystectomy
32 Unknown  Laparo-endoscopic Single Site (LESS) Cholecystectomy Versus Standard LAP-CHOLE
Condition: Cholelithiasis
Intervention: Procedure: Cholecystectomy
33 Completed Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
Conditions: Gallbladder Cancer;   Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin
34 Completed Pain Post Abdominal Laparoscopy Prevention With Arcoxia
Conditions: Laparoscopic Surgery for Appendicitis;   Laparoscopic Surgery for Cholecystitis;   Laparoscopic Surgery for Ovarian Cysts
Intervention: Drug: etoricoxib 120 mg
35 Withdrawn Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Gallbladder;   Adenocarcinoma With Squamous Metaplasia of the Gallbladder;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Stage II Gallbladder Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: selumetinib;   Drug: Akt inhibitor MK2206;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Procedure: quality-of-life assessment
36 Completed Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis
Conditions: Choleclithiasis;   Common Bile Duct Stones
Interventions: Procedure: ERCP;   Procedure: LapCBDE
37 Unknown  Hybrid Transvaginal-Transabdominal Endoscopic Surgery
Conditions: Gallstones;   Appendicitis;   Pelvic Pain;   Peritoneal Mass
Intervention: Procedure: Hybrid Transvaginal-Transabdominal Endoscopic Surgery
38 Unknown  Safety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies
Condition: Cholecystolithiasis
Interventions: Procedure: Single Trocar CCK;   Procedure: Standard CCK
39 Completed Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct Stones
Condition: Common Bile Duct Stones.
Interventions: Procedure: preoperative ERCP and LC;   Procedure: Intraoperative ERCP and LC
40 Not yet recruiting Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy
Conditions: Gallbladder Polyp;   Asymptomatic Gallstones Without Cholecystitis
Interventions: Drug: Lidocaine;   Drug: Dexamethasone

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years